Mustang Bio, Inc. (MBIO): Total Liabilities
$8.06M
As of 2025-12-31
$8.07M
As of 2026-06-30
-44.1%
3-year compound annual growth
-6.8%
5-year compound annual growth
+6.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.06M | -38.8% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $13.18M | -25.2% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $17.62M | -61.8% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $46.15M | +261.4% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $12.77M | +11.4% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $11.46M | -47.4% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $21.79M | +242.8% | 2021-03-24, Balance as of period end |
| 2018-12-31 | $6.36M | +73.7% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $3.66M | +13.6% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $3.22M | -21.9% | 2018-03-29, Balance as of period end |
| 2015-12-31 | $4.13M | n/a | 2017-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | $8.06M | -38.8% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.85M | -85.8% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $2.53M | +67.1% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | $10.26M | -54.1% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | $12.56M | -47.3% |
| Genelux Corp (GNLX) | 2025-12-31 | $7.48M | -11.4% |
Compare MBIO, LSTA, IBO, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗